Brett Cooper Ph.d

Brett Cooper, Ph.D, FRSC, has a diverse and extensive work experience. Brett has worked as a Senior Principal Scientist and Principal Scientist at Pharmaron UK Ltd, where they led teams of Analytical Scientists in supporting the Process Chemistry team and conducting method development, validation, and stability programs. Brett also served as an Associate Principal Scientist at AstraZeneca, leading early pharmaceutical development teams and characterizing drug candidates for preclinical studies. Additionally, they worked as a Pharmaceutical Development Manager at PAION UK Ltd, overseeing the drug product development of Remimazolam. Furthermore, Brett has held roles at various organizations such as the Joint Pharmaceutical Analysis Group (JPAG) and the Industrial Group of the British Crystallographic Association, where they contributed as an officer and committee member. Brett was also a Research Fellow and Principal Scientist at Merck, involved in the development of preliminary market formulations and leading product development teams. Overall, Brett Cooper's work experience demonstrates their expertise in analytical chemistry, pharmaceutical development, and leadership roles within the industry.

Brett Cooper, Ph.D, FRSC, pursued their education in Chemistry from 1981 to 1988, completing A Levels at Adams Wem. Brett then enrolled at the University of Birmingham, where they successfully obtained a BSc and PhD in Chemistry from 1988 to 1995.